PET Evaluation of Recurrent Differentiated Thyroid Cancer (THYROPET)
Recurrent Differentiated Thyroid Cancer: Towards Personalized Treatment Based on Evaluation of Tumor Characteristics With PET (THYROPET
Sponsor: Amsterdam UMC, location VUmc
A observational or N/A phase clinical study on Differentiated Thyroid Cancer and Thyroid Neoplasms, this trial is ongoing. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 8 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — May 2022 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- The Netherlands Cancer Institute
- UMC Utrecht
For direct contact, visit the study record on ClinicalTrials.gov .